Surgical management of cardiac hydatidosis

Jaffar Shehatha1, Mustafa Alward, Pankaj Saxena

  • 1Department of Cardiothoracic Surgery, Ibn-Alnafis Teaching Hospital, Baghdad, Iraq.

Insights

Cardiac hydatidosis is a rare condition, affecting only 0.5% to 2% of hydatidosis patients. This study details four successful surgical cases of cardiac hydatid cysts, with all patients disease-free post-treatment.

Area of Science:

  • Medicine
  • Parasitology
  • Cardiology

Background:

  • Cardiac hydatidosis is an extremely rare parasitic infection, with hydatid cysts typically found in the liver or lungs.
  • Only 0.5% to 2% of patients with hydatidosis present with cardiac cysts, making it a seldom-reported condition in medical literature.

Purpose of the Study:

  • To present the clinical summaries of four patients diagnosed with cardiac hydatid cysts.
  • To discuss the surgical technique employed for treating cardiac hydatidosis.
  • To highlight the outcomes of surgical intervention and medical therapy for this rare condition.

Main Methods:

  • Retrospective review of clinical data for four patients with cardiac hydatid cysts.
  • Surgical treatment and medical therapy were administered to all patients.
  • Follow-up assessment one year after treatment to evaluate disease eradication.

Main Results:

  • Cardiac hydatid cysts represented 0.5% of all thoracic hydatidosis surgeries performed over 20 years (4 out of 763 patients).
  • All four patients underwent successful surgical treatment and medical therapy.
  • One year post-treatment, all patients were confirmed to be free of hydatid disease.

Conclusions:

  • Cardiac hydatidosis, though rare, can be effectively treated with surgical intervention and medical management.
  • The presented operative technique and therapeutic approach led to complete disease eradication in the studied cases.
  • Early diagnosis and prompt treatment are crucial for favorable outcomes in patients with cardiac hydatidosis.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...